We provide you with 20 years of free, institutional-grade data for CODX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of CODX. Explore the full financial landscape of CODX stock.
| Reported Date | CIK | Ticker | Type |
|---|
Co-Diagnostics, Inc(NASDAQ:CODX) 
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis ...
Website: http://www.codiagnostics.com
Founded: 2013
Full Time Employees: 39
Sector: Healthcare
Industry: Diagnostics & Research
The information provided in this report about CODX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.